Kevin D. Freeman - Director at Galectin Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
GALT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Kevin D. Freeman - trading volume in the past year for Galectin Therapeutics Inc

Holdings reported by Kevin D. Freeman for Galectin Therapeutics Inc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 75,000 $178 K $2.38 Jun 20, 2024 By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC
Common Stock 28,469 $67.8 K $2.38 Jun 20, 2024 Direct
Common Stock 18,063 $43 K $2.38 Jun 20, 2024 IRA
Stock Option (right to buy) 50,000 Jan 24, 2024 Direct Common Stock

Transactions reported by Kevin D. Freeman for Galectin Therapeutics Inc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership